Company Analysis

Coherus Oncology, Inc. (CHRS)

Nasdaq: CHRS · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2011
Grade4.8
◀ Past 3.5● Present 5.6▶ Future 5.0
1 est.

Filings

400 filings since 2017 beside 282 insider forms · Accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextAccelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Accelerated filers have 75 days after the fiscal year ends. by Mar 16, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Apr 20, 2026.

Filings a yearinsider forms included
7367656189715851
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Jun 15, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Jul 3, 2025.Officer or director change (8-K item 5.02): 8 times in the last 36 months, the newest Apr 25, 2025.Debt trigger or default notice (8-K item 2.04): 1 time in the last 36 months, the newest Mar 4, 2024.SEC letters: 4 in the last 36 months, the newest Dec 5, 2025.
Insider forms 282

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026 10-Q Quarterly report Sep 30, 2026
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 29, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Oct 28, 2026
Aug 28, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 28, 2026 424B5 Shelf offering
Aug 28, 2026 424B3 Shelf offering
Aug 17, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Aug 17, 2026 8-K items 1.01, 1.02, 2.03, 9.01 Major agreement signed; Major agreement ended; New debt or obligation taken on · Current report
Aug 5, 2026 S-8 Employee stock plan registration
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 27, 2026 SCHEDULE 13G Large holder notice
Jun 15, 2026 8-K items 4.01, 9.01 Auditor change · Current report Jun 12, 2026
Jun 1, 2026 8-K item 5.07 Shareholder vote · Current report May 27, 2026
May 28, 2026 DEFA14A Extra proxy material
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 11, 2026 SCHEDULE 13G/A Large holder update, amended
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
May 5, 2026 DEFA14A Extra proxy material
Apr 29, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 27, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 20, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 20, 2026 DEF 14A Proxy statement May 27, 2026
Apr 14, 2026 DEFA14A Extra proxy material
Apr 9, 2026 PRE 14A Preliminary proxy statement May 27, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 9, 2026 10-K Annual report Dec 31, 2025
Mar 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 8-K items 8.01, 9.01 Other event · Current report Feb 12, 2026
Feb 13, 2026 424B5 Shelf offering
Feb 12, 2026 424B5 Shelf offering
Feb 5, 2026 SCHEDULE 13G Large holder notice
Feb 4, 2026 8-K item 8.01 Other event · Current report
Jan 30, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 23, 2026 8-K items 8.01, 9.01 Other event · Current report
Jan 23, 2026 424B5 Shelf offering
Jan 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Dec 8, 2025 EFFECT Registration effective
Dec 5, 2025 CORRESP Reply to the SEC
40 of 400 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton CHRS · research, not advice